Journal
EMERGING INFECTIOUS DISEASES
Volume 12, Issue 1, Pages 151-154Publisher
CENTERS DISEASE CONTROL
DOI: 10.3201/eid1201.050916
Keywords
-
Categories
Ask authors/readers for more resources
We report a novel parvovirus (PARV4) and related variants in pooled human plasma used in the manufacture of plasma-derived medical products. Viral DNA was detected by using highly selective polymerase chain reaction assays; 5% of pools tested positive, and amounts of DNA ranged from < 500 copies/mL to > 10(6) copies/mL plasma.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
